SEARCH RESULTS FOR:

Petrochemicals & Chemicals
Malaysia

Akbar Thayoob

PRESIDENT, MALAYSIAN PETROCHEMICALS ASSOCIATION (MPA)
"The dynamics of competition are highly fluid today, and I believe the industry will find success in well-defined, specifically targeted products rather than by competing with the same undifferentiated products."
United States
Pharma & Life Sciences

Gil Roth

PRESIDENT, PBOA
"The Ukraine crisis highlighted how Europe needs to look at its energy supply and how it will make sure they have secure supply chains. Part of that has involved the US more closely. Geopolitics will have a more significant impact going forward."
United States
Pharma & Life Sciences

Terry Myerson

CEO, TRUVETA
"Truveta Studio is the first data and analytics solution to study patient care and outcomes for all conditions, drugs, and medical devices. Pfizer is using Truveta Studio to study COVID-19."
Mining
Canada

Juice Lambert

PRESIDENT, TITAN ENVIRONMENTAL CONTAINMENT
"We must work toward both human safety and environmental safety, and because our products typically prevent issues such as seepage and contamination of the soil and groundwater, mistakes can be very dangerous."
Mining
Canada

Nigel Fung & Neal Reynolds

PARTNER AMERICAS (NF) & PARTNER (NR), CSA GLOBAL
"Advanced data analysis is a huge growth area, and we are overloaded with opportunities for our team to address issues to optimize operations at the study and operational stages."
Mining
Ghana
MACIG

James Longshore

CO-FOUNDER AND CEO, XTRA-GOLD RESOURCES
"I strongly believe Kibi has room to grow into a multi-million oz deposit and become the next big discovery in Ghana."
Mining
MACIG

Oliver Dallaway

DIRECTOR, AFRICAN MINING SERVICES (AMS)
"The whole point of our work in the country is to empower Congolese people and give them a sense of achievement. AMS only hires locally."
Pharma & Life Sciences
India

Ajay Tandon

MANAGING DIRECTOR, VEEDA CLINICAL RESEARCH
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."
Pharma & Life Sciences
India

Gaurav Kaushik

MANAGING DIRECTOR AND CEO, METEORIC BIOPHARMACEUTICALS
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
United States
Pharma & Life Sciences

Liping Liu

FOUNDER & CEO, HIGHTIDE THERAPEUTICS
"As more robust drug candidates are emerging, I am willing to bet that we will have the first NASH drug approved in 2023."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL